All stock reports

SOMATEX evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-10-01T23:41:47.110157+00:00

Metrics

latest_annual_period
2026-03-31
revenue
808800000.0
net_income
98200000.0
operating_cash_flow
-1027000000.0
free_cash_flow
-1028200000.0
total_assets
2288100000.0
total_liabilities
611400000.0
total_equity
1676700000.0
cash
5800000.0
total_debt
2900000.0
revenue_growth
7.5226554267650165
earnings_growth
-0.8582358885520427
net_margin
0.12141444114737883
roe
0.058567424106876605
debt_to_equity
0.001729587880956641
cash_conversion
-10.458248472505092
free_cash_flow_margin
-1.2712660731948566
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Evidence unavailable. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-aef0b814093866bd0a3baeb5cbd0029e675e160fd40a321c6a1170d2c0da7aea
Policy
stock-decisions-v1
Evidence bundle hash
4e53e6ce067b2ee2600a1fee4886de38131b02652b40d4561469ab84ab051567
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: ec28491f8f5f8673d2b43145943a48df6e27b39aef76aafa1424d1ebc97959e1
  • daily-price: 2e6b40702d58a714e6f4e2f309adb37fc7562738e4128043f6d773eca406394d
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits